These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30892778)

  • 1. Successful ceftazidime-avibactam treatment of post-surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis.
    Daccò V; Claut L; Piconi S; Castellazzi L; Garbarino F; Teri A; Colombo C
    Transpl Infect Dis; 2019 Jun; 21(3):e13082. PubMed ID: 30892778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
    Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
    ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime-avibactam.
    Los-Arcos I; Len O; Martín-Gómez MT; González-López JJ; Saéz-Giménez B; Deu M; Nuvials X; Ferrer R; Román A; Gavaldà J
    Infection; 2019 Apr; 47(2):289-292. PubMed ID: 30565008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series.
    Spoletini G; Etherington C; Shaw N; Clifton IJ; Denton M; Whitaker P; Peckham DG
    J Antimicrob Chemother; 2019 May; 74(5):1425-1429. PubMed ID: 30649419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftazidime plasma concentration in a patient with cystic fibrosis treated with ceftazidime/avibactam plus trimethoprim/sulfametoxazole for
    Saffioti C; Barco S; Cangemi G; Mesini A; Casciaro R; Cresta F; Castellani C; Bandettini R; Morelli P; Castagnola E
    J Chemother; 2019; 31(7-8):436-438. PubMed ID: 31583970
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam.
    Tamma PD; Fan Y; Bergman Y; Sick-Samuels AC; Hsu AJ; Timp W; Simner PJ; Prokesch BC; Greenberg DE
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29588357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pan-resistant Burkholderia cepacia complex bacteremic pneumonia, after lung transplantation treated with a targeted combination therapy.
    Cantón-Bulnes ML; Hurtado Martínez Á; López-Cerero L; Arenzana Seisdedos Á; Merino-Bohorquez V; Garnacho-Montero J
    Transpl Infect Dis; 2019 Apr; 21(2):e13034. PubMed ID: 30548546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of resistant Burkholderia multivorans infection in a patient with cystic fibrosis using ceftazidime/avibactam plus aztreonam.
    Barlow G; Morice A
    J Antimicrob Chemother; 2018 Aug; 73(8):2270-2271. PubMed ID: 29912407
    [No Abstract]   [Full Text] [Related]  

  • 10. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy?
    Horsley A; Webb K; Bright-Thomas R; Govan J; Jones A
    Front Cell Infect Microbiol; 2011; 1():18. PubMed ID: 22919584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
    Kitt H; Lenney W; Gilchrist FJ
    BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel antibiotic combinations proposed for treatment of
    El-Halfawy OM; Naguib MM; Valvano MA
    Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
    Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
    Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Van Dalem A; Herpol M; Echahidi F; Peeters C; Wybo I; De Wachter E; Vandamme P; Piérard D
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in ceftazidime-avibactam activity against multidrug-resistant organisms recovered from respiratory samples of cystic fibrosis patients.
    Farfour E; Trochu E; Devin C; Cardot Martin E; Limousin L; Roux A; Picard C; Jolly E; Vasse M; Lesprit P
    Transpl Infect Dis; 2018 Oct; 20(5):e12955. PubMed ID: 29896802
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP; Dos Santos SC; Madeira A; Mira NP; Moreira AS; Sá-Correia I
    Front Cell Infect Microbiol; 2011; 1():12. PubMed ID: 22919578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of
    Schaumburg F; Idelevich EA; Mellmann A; Kahl BC
    Microb Drug Resist; 2022 May; 28(5):545-550. PubMed ID: 35512733
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia dolosa (genomovar VI).
    Wang R; Welsh SK; Budev M; Goldberg H; Noone PG; Gray A; Zaas D; Boyer D
    Clin Transplant; 2018 May; 32(5):e13236. PubMed ID: 29528522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.
    da Costa Capizzani CP; Caçador NC; Torres LAGMM; Tonani L; Vandamme P; da Costa Darini AL
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2263-2271. PubMed ID: 28840370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a cystic fibrosis patient.
    Stokell JR; Gharaibeh RZ; Steck TR
    J Cyst Fibros; 2013 Dec; 12(6):812-6. PubMed ID: 23478130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.